Columbia University

Technology Ventures

Science Center Research Acceleration Initiative

Deadline: 
Monday, April 13, 2020 - 5:00pm

Interested investigators can sign up to attend office hours on March 3 with CSL and CTV here

 
CSL Behring is a leading global biotechnology company that develops and delivers innovative biotherapies to help people living with life threatening medical conditions live full lives. CSL has partnered with the University City Science Center, a nonprofit institution that has been dedicated to identifying and nurturing promising technology for over half a century, to build the CSL-Science Center Research Acceleration Initiative. The initiative is designed to source research and fast-track discovery through partnerships between CSL and regional research institutions. Selected projects receive funding and access to industry resources for scientists working on novel technologies in CSL’s therapeutic areas.
 
Funding Mechanism
The Initiative will fund up to three proposals in 2020. Successful applicants will receive up to $200,000 per year for up to two years (maximum $400,000 funding) to accelerate translation of their research. Because the awards will be in the form of research partnerships, interested investigators must engage Columbia Technology Ventures (techventures@columbia.edu) prior to submitting an application. 
 
Applications will be accepted through April 13, 2020. For more information and to submit proposals, please visit our website: www.sciencecenter.org/discover/csl 
For questions regarding the initiative and details of partnering with CSL, email RAI.US@cslbehring.com
 
The CSL – Science Center Research Acceleration Initiative seeks innovations that address CSL Therapeutic and Focus areas, and that are amenable to or include a listed Modality below:
 
Therapeutic Areas (emphasis on rare disease):
  • Immunology
  • Neurology
  • Haematology
  • Thrombosis
  • Transplant
  • Respiratory
  • Cardiovascular/Metabolic

Focus Areas:

  • Novel drug targets
  • Novel therapeutic candidates
  • Novel strategies for treating disease

Modalities:

  • Antibodies
  • Protein therapeutics
  • Gene therapies
  • Cell therapies
  • Small molecules not of interest

Timeline and Information:

March 2, 2020: Opening day for pre-proposal applications. 
April 13, 2020: Deadline for receipt of pre-proposal applications. 
June 25, 2020: Finalist applicants present research proposals at SC to CSL
July 30, 2020: Finalist applicants selected for funding